Skip to content

Author

Paul Aisen

We have 3 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

ATRI LIMS: a cloud-native open-source laboratory information management system for biomarker-driven Alzheimer’s disease clinical trials

Abstract Objectives This article summarizes the architecture, design principles, and implementation strategy of the ATRI Laboratory Information Management System (LIMS), a cloud‑native, open‑source platform supporting biomarker‑driven Alzheimer’s disease (AD) clinical research. The system addresses challenges associate...

G. Jimenez-Maggiora, S. Bruschi, S. Abdel-Latif et al. · 0 citations
Open access Sep 2026

Sex-specific biological aging clocks across organs and omics

Sex differentially shapes aging, neurodevelopment, and neurodegenerative diseases such as Alzheimer’s disease (AD). Yet, most biological aging clocks (AI-predicted age minus chronological age) were trained on sex-pooled samples and implicitly assume sex invariance. Here, we develop 38 sex-specific biological aging cloc...

Zhi-Yuan Song, Derek Feng, Naowal Azraf Rahman et al. · 0 citations
Open access Sep 2026

CSF proteomics and machine learning reveal distinct stages across the Alzheimer’s disease continuum

These findings uncover protein signatures that reflect underlying AD biology and provide a foundation for stage-specific biomarkers and therapeutic targeting, with important implications for patient stratification and personalized intervention strategies.

Saima Rathore, E. Dammer, Anantharaman Shantaraman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.